Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 3—March 2022
Research

Genomic and Phenotypic Insights for Toxigenic Clinical Vibrio cholerae O141

Yaovi M.G. HounmanouComments to Author , Brandon Sit, Bolutife Fakoya, Matthew K. Waldor, and Anders Dalsgaard
Author affiliations: University of Copenhagen, Frederiksberg, Denmark (Y.M.G. Hounmanou, A. Dalsgaard); Brigham & Women’s Hospital, Boston, Massachusetts, USA (B. Sit, B. Fakoya, M.K. Waldor); Harvard Medical School, Boston (B. Sit, B. Fakoya, M.K. Waldor)

Main Article

Table

Characteristics of whole-genome sequences of Vibrio cholerae O141 strains*

Strain GC, % No. contigs Length, bp N50 of contigs Place and year of isolation cgMLST†
AD3_609–84 47.5 136 3,959,387 195,630 USA, 1984 479
AD4_2454–85 47.44 145 4,110,364 104,771 USA, 1985 479
AD5_2466–85 47.42 134 4,096,622 111,701 USA, 1985 479
AD6_2527–87 47.52 140 4,073,408 111,688 USA, 1987 479
AD7_2533–86 47.41 150 4,056,508 157,587 USA, 1986 479
AD8_F2031 47.43 101 3,976,610 187,293 Spain, 1994 246
AD9_234–93 47.5 130 4,046,144 185,481 India, 1993 479
AD10_1178–96 47.41 118 4,082,579 101,628 Taiwan, 1993 479

*cgMLST, core genome multilocus sequence type; N50, shortest contig length covering 50% of the genome. †The conventional 7-gene MLST profile is ST42 for all.

Main Article

Page created: January 05, 2022
Page updated: February 21, 2022
Page reviewed: February 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external